BHC - צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים Bausch Health Corp

Bausch Health Companies (BHC) relies on inelastic demand in gastroenterology and ophthalmology, maintaining moderate pricing power due to its debt load. This rolling year-over-year revenue growth chart confirms this trend, where the 10.80 level indicates the parameter's status. The sale of lenses and prescription drugs to clinics serves as a cash generator. The industry's humanitarian status and diversified supply chains guarantee stability.
Bausch Health Companies Inc. (BHC) - פילוחי מדדים ודוחות פיננסיים

For Bausch Health Companies (BHC), which relies on trust in the Bausch + Lomb brands and dermatology drugs, this indicator serves as a measure of market expansion. The metric calculates the percentage change in revenue over the last twelve months, excluding quarterly distortions. By analyzing the annual revenue growth from sales over a rolling period, an investor can see the real demand dynamics. Sharp deviations on the chart signal business overheating or stagnation.